Study to Predict Risk of Adverse Events in Chinese Adults Aged 18 to 45 With Premature Coronary Heart Disease

What this Trial Is About

Researchers are investigating risk factors and prognosis differences in Chinese individuals under 45 years old with premature coronary artery disease. This observational cohort study aims to create a model predicting adverse events, such as cardiac death, heart attacks, strokes, and repeat procedures, over a two-year period. The study is led by the China National Center for Cardiovascular Diseases and focuses on understanding outcomes for different patient types without introducing any mandatory treatments. Participants will not receive any study treatments but will be observed over two years. Blood tests are scheduled at the one-year mark, and participants will have follow-up visits or telephone interviews at various intervals. The study collects detailed information on major adverse cardiac and cerebrovascular events MACCE and tracks their sensitivity and specificity in prediction. Additional outcomes include rates of death, heart attacks, revascularizations, stent thrombosis, strokes, and bleeding events, measured regularly throughout the two years. During the study, participants will undergo blood tests, outpatient visits, or phone interviews to monitor their health status. Researchers will assess the occurrence of cardiac events and other complications to develop a prediction model. The study involves no active intervention, focusing on observation and data collection for two years to better understand risk factors and outcomes in this patient group.

Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial